Griffyn Robotech Will Manufacture and Supply Mass Ventilators to the Government of India

▴ Griffyn Robotech Will Manufacture and Supply Mass Ventilators to the Government of India
Due to shortage of ventilators, caretakers and medical staff uses bag valve mask devices to manually ventilate patients for prolonged periods of time leading to mortality and morbidity. To address this, Griffyn Robotech has developed affordable AI specilized ventilation devices to treat patients

With COVID-19 cases multiplying at an alarming rate, Griffyn Robotech, an Artificial Intelligence (AI) innovations company headquartered in Pune, has announced manufacturing and mass supply of ventilators to support the Government of India in the fight against COVID-19 virus. The lethal coronavirus is known to affect the respiratory system of the patient who is required to be put on a ventilator, a machine that adds pressure to pump oxygen into the bloodstream and take out carbon dioxide from the lungs of the patient.

According to estimates by Government of India, the country needs 50,000 ventilators over the next two months. While the government has fast-tracked imports, the bulk of this shortfall has to be met by domestic manufacturers to fulfill the supply and demand gap. In this hour of crisis, Griffyn Robotech, with its other partners, scheduled for a Webex meeting to discuss the impact of the pandemic and initiatives that can be implemented to help the nation. The company was inspired by MIT ventilator design and created its own design using 3D printing technology to bring to the market 'Shwaas' an Ambu-bag based ventilator in the fight against COVID-19.

Speaking about the AI enabled ventilator, Mr. Amit Mahajan, Founder & CEO of Griffyn Robotech Pvt. Ltd., said, "Ventilators and other respiratory aids are critical devices in the fight against COVID-19, and to this end we are working together with our partners to ensure manufacturing and steady supply of ventilators in India. As a socially responsible and caring brand, we are committed to serving society in every way possible."

"Further to this effect, we will be creating an open API and extensible platform that can be leveraged for extended features to be rapidly introduced in next few weeks. We are also planning to collaborate with other start-ups for creating addons to the platform. We are all proud 'Desh Bhakts' and are glad to contribute with our skills so that we all win together the fight against the pandemic."

He further adds, "We will be applying to be one of the many suppliers to the government to manufacture ventilators on a large scale that can save millions of lives across India and globally to combat the COVID-19 pandemic. This will ensure we have enough ventilators and are prepared to tackle the coronavirus outbreak."

Due to shortage of ventilators, caretakers and medical staff uses bag valve mask devices to manually ventilate patients for prolonged periods of time leading to mortality and morbidity. To address this, Griffyn Robotech has developed affordable AI specilized ventilation devices to treat patients with respiratory illnesses during emergencies and mass casualties, as an alternative for prolonged manual ventilation.

As per recent reports, India which only spends about 1 per cent of its gross domestic product on healthcare, has allocated fewer than 20,000 ventilators for the treatment of COVID-19 patients. The public health research organisation, based in Washington and New Delhi, estimates India will need as many as 1m ventilators to address the peak of coronavirus cases.

Tags : #Griffynrobotech #Massventilators #AI

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024